/ CompletedNot ApplicableIIT Clinical Implementation of Metagenomic Next-Generation Sequencing for Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort
This study aims to use a clinically validated metagenomic next-generation sequencing (mNGS) assay to provide a demonstration of precision medicine for diagnosis of acute infectious disease in hospitalized patients. From June 2016 to June 2017, 200 patients will be enrolled from multiple hospitals in California and outside of California. Patients will be evaluated to determine the impact on the mNGS assay on diagnostic yield, hospital costs and clinical outcomes.
100 Clinical Results associated with Charles and Helen Schwab Foundation
0 Patents (Medical) associated with Charles and Helen Schwab Foundation
100 Deals associated with Charles and Helen Schwab Foundation
100 Translational Medicine associated with Charles and Helen Schwab Foundation